Marketing-authorisation holder

VANCOCIN ITALIA Srl

2 medicines2 countries

2 medicines in 2 countries, as authorisation holder.

Medicines

Every medicine in the registers under its name, current ones first.

2 medicines

Medicine	Substance	Country	Status	Authorised
MULPLETA3MG · Tablet	Lusutrombopag	United States	Marketed	2018
VANCOCINA A.P.Polvere per concentrato per soluzione per infusione	Vancomycin	Italy	Authorised

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
Italy	1	1	0	Companies All medicines
United States	1	1	0	Companies All medicines

Therapeutic areas

The ATC groups most of its medicines belong to, largest first.

Antibacterials for systemic useAnti-infectives for systemic use · ATC J01X

Top substances

The active substances in most of its medicines.

Names in the registers

How the registers spell it, normalised: legal forms, accents and capitals removed.

vancocin italia

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.